Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

NCT00176423 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: galantamine

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]